May 2015 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2014/15 Invitation to Tender, dated 6 November 2014.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.

Where a product does not have a current Pharmacode, suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand before the 12th of the month prior to the date of listing. PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2014/15 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2018

CORRECTION to April 2015 tender notification: in bold and strikethrough

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand (Supplier) Date of listing/subsidy change for tender winning brand Date of reference pricing of other listed brands Sole Subsidised Supply date (and delisting of other listed brands) Brand (Supplier) affected by reference pricing and delisting
Zopiclone 1 Tab 7.5 mg;
500 tablet,blister bottle pack
$11.90 $8.99 Zopiclone Actavis
(Actavis)
1 October 2015 1 December 2015 1 March 2016 Apo-Zopiclone
(Apotex)
1  Brand switch fee of $4.33 is payable for this product from 1 March 2016 until 1 June 2016

 

CORRECTION to April 2015 tender notification: in bold and strikethrough

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Pack Price Hospital SupplyBrand (Supplier) DVLimit Listing date Hospital Supply Status date
Zopiclone Tab 7.5 mg;
500 tablet, blister bottle pack
$11.90 $8.99 Zopiclone Actavis
(Actavis)
1% 1 October 2015 1 December 2015

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Sole supply brand
(Supplier)
Date of subsidy change Sole Subsidised Supply date
Pancreatic enzyme Cap EC 25,000 BP u lipase, 18,000 BP u amylase and 1,000 BP u protease;
100 capsule, bottle pack
$94.38 $94.38 Creon 25000
(Abbott)
1 August 2015 1 November 2015
Pancreatic enzyme Cap EC 10,000 BP u lipase, 9,000 BP u amylase and 210 BP u protease;
100 capsule, bottle pack
$34.93 $34.93 Creon 10000
(Abbott)
1 August 2015 1 November 2015
Paracetamol Suppos 500 mg;
50 suppositories
$20.70 $12.60 Paracare
(API)
1 September 2015 1 December 2015
Sodium cromoglycate Eye drops 2%;
5 ml OP
$1.18 $0.85 Rexacrom
(Rex Medical)
1 July 20151 September 2015 1 October 2015
1 December 2015

Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current subsidy (and price)

New subsidy (and price)

Sole supply brand (Supplier)

Date of listing/subsidy change for tender winning brand

Date of reference pricing of other listed brands

Sole Subsidised Supply date (and delisting of other listed brands)

Brand (Supplier) affected by reference pricing and delisting

Acetylcysteine1

Inj 200 mg per ml, 10 ml ampoule;

10 ampoules

$178.00

$78.34

DBL Acetylcysteine (Hospira)

1 July 2015

1 September 2015

1 December 2015

Martindale Acetylcysteine

(Max Health)

Acetadote

(AFT)

Bosentan

Tab 62.5 mg;

56 tablet, blister pack

$1,500.00 per 60 tablets, and

$4,585.00 per 60 tablets

$375.00 per 56 tablets

Mylan-Bosentan (Mylan)

1 August 2015

1 December 2015

1 March 2016

Pms-Bosentan

(AFT)

Tracleer

(Actelion)

Bosentan

Tab 125 mg;

56 tablet, blister pack

$1,500.00 per 60 tablets, and

$4,585.00 per 60 tablets

$375.00 per 56 tablets

Mylan-Bosentan (Mylan)

1 August 2015

1 December 2015

1 March 2016

Pms-Bosentan

(AFT)

Tracleer

(Actelion)

Chlorhexidine gluconate

Soln 4% wash; 500 ml

$5.90

$3.98

healthE (Jaychem)

1 August 2015

1 October 2015

1 January 2016

Orion

(Orion)

Citalopram hydrobromide 2

Tab 20 mg;

84 tablet, blister pack

$2.34

$1.79

PSM Citalopram

(API)

1 October 2015

1 December 2015

1 March 2016

Arrow-Citalopram

(Actavis)

Cyclizine hydrochloride

Tab 50 mg;

20 tablet, blister pack

$0.59 per 10 tablets

$0.59 per 20 tablets

Nauzene

(Actavis)

1 November 2015

1 January 2016

1 April 2016

Nausicalm

(AFT)

Desferrioxamine mesilate

Inj 500 mg vial;

10 vials

$109.89

$51.52

Desferal

(Novartis)

1 December 2015

1 February 2016

1 May 2016

Hospira

(Hospira)

Dexamethasone3

Tab 0.5 mg;

30 tablet, bottle pack

$5.87 per 100 tablets of tab 1 mg

$0.88 per 30 tablets of tab 0.5 mg

Dexmethsone (Aspen)

1 November 2015

1 January 2016

1 April 2016

Douglas

(Douglas)

Dexamethasone

Tab 4 mg;

30 tablet, bottle pack

$8.16 per 100 tablets

$1.84 per 30 tablets

Dexmethsone (Aspen)

1 November 2015

1 January 2016

1 April 2016

Douglas

(Douglas)

Lansoprazole

Cap 15 mg;

100 capsule, bottle pack

$2.00 per 28 tabletscapsules

$5.08 per 100 tabletscapsules

Lanzol Relief (Mylan)

1 November 2015

1 January 2016

1 April 2016

Solox

(Douglas)

Lansoprazole

Cap 30 mg;

100 capsule, bottle pack

$2.32 per 28 tabletscapsules

$5.93 per 100 tabletscapsules

Lanzol Relief (Mylan)

1 November 2015

1 January 2016

1 April 2016

Solox

(Douglas)

Metformin hydrochloride

Tab immediate-release 850 mg;

500 tablet, bottle pack

$10.10

$7.82

Metformin Mylan (Mylan)

1 October 2015

1 December 2015

1 March 2016

Apotex

(Apotex)

Oil in water emulsion

Crm; 500 g

$2.63

$2.25

O/W Fatty Emulsion Cream

(Boucher)

1 November 2015

1 January 2016

1 April 2016

healthE Fatty Cream

(Jaychem)

Paracetamol

Suppos 125 mg;

10 suppositories

$7.49 per 20 tabletssuppositories

$3.69 per 10 tabletssuppositories

Gacet

(AFT)

1 October 2015

1 December 2015

1 March 2016

Panadol

(GSK)

Paracetamol

Suppos 250 mg;

10 suppositories

$14.40 per 20 tabletssuppositories

$3.79 per 10 tabletssuppositories

Gacet

(AFT)

1 October 2015

1 December 2015

1 March 2016

Panadol

(GSK)

Pioglitazone

Tab 15 mg;

90 tablet, bottle pack

$1.50 per 28 tablets

$3.47 per 90 tablets

Vexazone

(Mylan)

1 October 2015

1 December 2015

1 March 2016

Pizaccord

(Douglas)

Pioglitazone

Tab 30 mg;

90 tablet, bottle pack

$2.50 per 28 tablets

$5.06 per 90 tablets

Vexazone

(Mylan)

1 October 2015

1 December 2015

1 March 2016

Pizaccord

(Douglas)

Pioglitazone

Tab 45 mg;

90 tablet, bottle pack

$3.50 per 28 tablets

$7.10 per 90 tablets

Vexazone

(Mylan)

1 October 2015

1 December 2015

1 March 2016

Pizaccord

(Douglas)

  1. Acetylcysteine inj 200 mg per ml, 30 ml will have a subsidy reduction from 1 September 2015 and will be delisted from Section B from 1 December 2015.

  2. Brand switch fee of $4.33 is payable for this product from 1 March 2016 until 1 June 2016.

  3. Dexamethasone tab 1 mg to be delisted 1 April 2016.

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

Tenders awarded to currently listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current subsidy  (and price) New subsidy (and price) Hospital Supply Brand(Supplier) DV Limit Listing date Hospital Supply Status date

Carmustine

Inj 100 mg vial;

1 vial

$532.00

$532.00

BiCNU

(Actavis)

1%

1 July 2015

1 September 2015

Flumazenil

Inj 0.1 mg per ml, 5 ml ampoule;

5 ampoules

$170.10

$85.05

Anexate

(Roche)

1%

1 July 2015

1 September 2015

Fluorouracil 1

Inj 50 mg per ml, 20 ml vial;

1 vial

$7.50

$10.00

Fluorouracil Ebewe

(Sandoz)

1%

1 August 2015

1 October 2015

Fluorouracil 1

Inj 50 mg per ml, 50 ml vial;

1 vial

$18.00

$17.00

Fluorouracil Ebewe

(Sandoz)

1%

1 August 2015

1 October 2015

Fluorouracil 1

Inj 50 mg per ml, 100 ml vial; 1 vial

$34.50

$30.00

Fluorouracil Ebewe

(Sandoz)

1%

1 August 2015

1 October 2015

Irinotecan hydrochloride 2

Inj 20 mg per ml, 2 ml vial;

1 vial

$9.34

$11.50

Irinotecan Actavis 40

(Actavis)

1%

1 July 2015

1 September 2015

Irinotecan hydrochloride 2

Inj 20 mg per ml, 5 ml vial;

1 vial

$23.34

$17.80

Irinotecan Actavis 100

(Actavis)

1%

1 July 2015

1 September 2015

Mitozantrone 3

Inj 2 mg per ml, 10 ml vial;

1 vial

$100.00

$97.50

Mitozantrone Ebewe

(Sandoz)

1%

1 July 2015

1 September 2015

Paracetamol

Suppos 500 mg;

50 suppositories

$20.70

$12.60

Paracare

(API)

1%

1 September 2015

1 November 2015

Tranexamic acid

Inj 100 mg per ml, 5 ml ampoule;

10 ampoules

$124.73

$55.00

Cyklokapron

(Pfizer)

1%

1 July 2015

1 September 2015

  1. The price and subsidy of fluorouracil (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 August 2015. The subsidy for fluorouracil inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.77 per 100 mg to $0.66 per 100 mg from 1 August 2015. Fluorouracil Ebewe inj 50 mg per ml, 10 ml vial to be delisted from Section H from 1 October 2015.
  2. The price and subsidy of irinotecan hydrochloride (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 July 2015. The subsidy for irinotecan hydrochloride inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.24 per 1 mg to $0.19 per 1 mg from 1 July 2015.
  3. The price and subsidy of mitozantrone (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above price from 1 July 2015. The subsidy for mitozantrone inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $5.65 per 1 mg to $5.51 per 1 mg from 1 July 2015. Mitozantrone Ebewe inj 2 mg per ml, 5 ml vial and Onkotrone inj 2 mg per ml, 12.5 ml vial to be delisted from 1 January 2016.


Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical Name Presentation;
Pack size and type
Current subsidy (and price) New subsidy (and price) Hospital Supply Brand (Supplier) DV Limit Listing date Hospital Supply Status date Brand (Supplier) affected by reference pricing and delisting

Acetylcysteine1

Inj 200 mg per ml, 10 ml ampoule;

10 ampoules

$178.00

$78.34

DBL Acetylcysteine

(Hospira)

1%

1 July 2015

1 September 2015

Martindale Acetylcysteine

(Max Health)

Acetadote

(AFT)

Aciclovir

Inj 250 mg vial;

5 vials

$14.09

$10.10

Aciclovir-Claris

(AFT)

1%

1 November 2015

1 January 2016

Zovirax IV

(GSK)

Bosentan

Tab 62.5 mg;

56 tablet, blister pack

$1,500.00 per 60 tablets, and

$4,585.00 per 60 tablets

$375.00 per 56 tablets

Mylan-Bosentan

(Mylan)

1%

1 August 2015

1 December 2015

Pms-Bosentan

(AFT)

Tracleer

(Actelion)

 

Bosentan

Tab 125 mg;

56 tablet, blister pack

$1,500.00 per 60 tablets, and

$4,585.00 per 60 tablets

$375.00 per 56 tablets

Mylan-Bosentan

(Mylan)

1%

1 August 2015

1 December 2015

Pms-Bosentan

(AFT)

Tracleer

(Actelion)

 

Carboplatin2

Inj 10 mg per ml, 5 ml vial;

1 vial

$20.00

$15.07

DBL Carboplatin

(Hospira)

1%

1 July 2015

1 September 2015

Carboplatin Ebewe

(Sandoz)

Carboplatin2

Inj 10 mg per ml, 15 ml vial;

1 vial

$19.50

$14.05

DBL Carboplatin

(Hospira)

1%

1 July 2015

1 September 2015

Carbaccord

(Actavis)

Carboplatin2

Inj 10 mg per ml, 45 ml vial;

1 vial

$48.50

$32.59

DBL Carboplatin

(Hospira)

1%

1 July 2015

1 September 2015

Carbaccord

(Actavis)

Cefepime hydrochloride

Inj 1 g vial;

1 vial

$8.80

$3.95

Cefepime-AFT

(AFT)

1%

1 August 2015

1 October 2015

DBL Cefepime

(Hospira)

Cefepime hydrochloride

Inj 2 g vial;

1 vial

$17.60

$6.92

Cefepime-AFT

(AFT)

1%

1 August 2015

1 October 2015

DBL Cefepime

(Hospira)

Cefoxitin sodium

Inj 1 g vial;

10 vial

$74.25 for 5 vials

$58.00 for 10 vials

Cefoxitin Actavis

(Actavis)

1%

1 November 2015

1 January 2016

Hospira

(Hospira)

Citalopram hydrobromide

Tab 20 mg;

84 tablet, blister pack

$2.34

$1.79

PSM Citalopram

(API)

1%

1 October 2015

1 December 2015

Arrow-Citalopram

(Actavis)

Cyclizine hydrochloride

Tab 50 mg; 20 tablet, blister pack

$0.59 per 10 tablets

$0.59 per 20 tablets

Nauzene (Actavis)

1%

1 November 2015

1 January 2016

Nausicalm

(AFT)

Desferrioxamine mesilate

Inj 500 mg vial;

10 vials

$109.89

$51.52

Desferal

(Novartis)

1%

1 December 2015

1 February 2016

Hospira

(Hospira)

Dexamethasone4

Tab 0.5 mg;

30 tablet, bottle pack

$5.87 per 100 tablets of tab 1 mg

$0.88 per 30 tablets of 0.5 mg

Dexmethsone

(Aspen)

1%

1 November 2015

1 January 2016

Douglas

(Douglas)

Dexamethasone

Tab 4 mg;

30 tablet, bottle pack

$8.16 per 100 tablets

$1.84 per 30 tablets

Dexmethsone

(Aspen)

1%

1 November 2015

1 January 2016

Douglas

(Douglas)

Dopamine hydrochloride

Inj 40 mg per ml, 5 ml ampoule;

5 ampoules

$69.77 per 10 ampoules

$16.89 per 5 ampoules

DBL Sterile Dopamine Concentrate

(Hospira)

1%

1 July 2015

1 September 2015

Martindale

(Max Health)

Doxorubicin hydrochloride3

Inj 2 mg per ml, 25 ml;

1 vial

$17.00

$11.50

Doxorubicin Ebewe

(Sandoz)

1%

1 December 2015

1 February 2016

Arrow-Doxorubicin

(Actavis)

Doxorubicin hydrochloride3

Inj 2 mg per ml, 100 ml vial;

1 vial

$65.00

$46.00

Doxorubicin Ebewe

(Sandoz)

1%

1 December 2015

1 February 2016

Arrow-Doxorubicin

(Actavis)

Lansoprazole

Cap 15 mg;

100 capsule, bottle pack

$2.00 per 28 tabletscapsules

$5.08 per 100 tabletscapsules

Lanzol Relief

(Mylan)

1%

1 November 2015

1 January 2016

Solox

(Douglas)

Lansoprazole

Cap 30 mg;

100 capsule, bottle pack

$2.32 per 28 tabletscapsules

$5.93 per 100 tabletscapsules

Lanzol Relief

(Mylan)

1%

1 November 2015

1 January 2016

Solox

(Douglas)

Metformin hydrochloride

Tab immediate-release 850 mg;

500 tablet, bottle pack

$10.10

$7.82

Metformin Mylan (Mylan)

1%

1 October 2015

1 December 2015

Apotex

(Apotex)

Paracetamol

Suppos 125 mg;

10 suppositories

$7.49 per 20 tabletssuppositories

$3.69 per 10 tabletssuppositories

Gacet

(AFT)

1%

1 October 2015

1 December 2015

Panadol

(GSK)

Paracetamol

Suppos 250 mg;

10 suppositories

$14.40 per 20 tabletssuppositories

$3.79 per 10 tabletssuppositories

Gacet

(AFT)

1%

1 October 2015

1 December 2015

Panadol

(GSK)

Pioglitazone

Tab 15 mg;

90 tablet, bottle pack

$1.50 per 28 tablets

$3.47 per 90 tablets

Vexazone

(Mylan)

1%

1 October 2015

1 December 2015

Pizaccord

(Douglas)

Pioglitazone

Tab 30 mg;

90 tablet, bottle pack

$2.50 per 28 tablets

$5.06 per 90 tablets

Vexazone

(Mylan)

1%

1 October 2015

1 December 2015

Pizaccord

(Douglas)

Pioglitazone

Tab 45 mg;

90 tablet, bottle pack

$3.50 per 28 tablets

$7.10 per 90 tablets

Vexazone

(Mylan)

1%

1 October 2015

1 December 2015

Pizaccord

(Douglas)

  1. Acetylcysteine inj 200 mg per ml, 30 ml to be delisted from Section H from 1 September 2015.
  2. Hospira’s brand of carboplatin (PCT only – Specialist) will be listed in Section B of the Pharmaceutical Schedule from 1 July 2015. The subsidy for carboplatin inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.13 per 1 mg to $0.08 per 1 mg from 1 September 2015. Carboplatin Ebewe inj 10 mg per ml, 100 ml vial to be delisted from Section H from 1 September 2015.
  3. The price and subsidy of doxorubicin hydrochloride (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 December 2015. The subsidy for doxorubicin hydrochloride inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.37 per 1 mg to $0.25 per 1 mg from 1 February 2016. Doxorubicin hydrochloride inj 50 mg vial to be delisted from Section H from 1 February 2016.
  4. Dexamethasone tab 1 mg to be delisted 1 January 2016.
  5. Tenders awarded to pharmaceuticals where no brand is listed.


Tenders awarded to pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Pack Price Hospital Supply Brand (Supplier) DV Limit Listing date Hospital Supply Status date

Dobutamine hydrochloride

Inj 12.5 mg per ml, 20 ml ampoule;

5 ampoules

$24.45

Dobutamine-Claris

(AFT)

1%

1 November 2015

1 January 2016

Daptomycin

Inj 350 mg vial;

1 vial

$175.16

Cubicin

(Novartis)

1%

1 July 2015

1 September 2015

Daptomycin

Inj 500 mg vial;

1 vial

$243.52

Cubicin

(Novartis)

1%

1 July 2015

1 September 2015

Doxorubicin hydrochloride 1

Inj 2 mg per ml, 50 ml vial;

1 vial

$23.00

Doxorubicin Ebewe

(Sandoz)

1%

1 December 2015

1 February 2016

Linezolid

Inj 2 mg per ml, 300 ml bag;

10 bags

$1,650.00

Zyvox

(Pfizer)

1%

1 July 2015

1 September 2015

Linezolid

Oral liq 20 mg per ml;

150 ml

$775.00

Zyvox

(Pfizer)

1%

1 July 2015

1 September 2015

Linezolid

Tab 600 mg;

10 tablet, blister pack

$800.00

Zyvox

(Pfizer)

1%

1 July 2015

1 September 2015

Pancreatic enzyme

Cap EC 25,000 BP u lipase, 18,000 BP u amylase and 1,000 BP u protease;

100 capsule, bottle pack

$94.38

Creon 25000

(Abbott)

1%

1 August 2015

1 October 2015

Pancreatic enzyme

Cap EC 10,000 BP u lipase, 9,000 BP u amylase and 210 BP u protease;

100 capsule, bottle pack

$34.93

Creon 10000

(Abbott)

1%

1 August 2015

1 October 2015

 

  1. The price and subsidy of doxorubicin hydrochloride (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above price from 1 December 2015. The subsidy for doxorubicin hydrochloride inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will change from $0.37 per 1 mg to $0.25 per 1 mg from 1 February 2016.

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in the 2013/14 Invitation to Tender, dated 7 November 2013, and the 2014/15 Invitation to Tender, dated 6 November 2014:

2013/14 Invitation to Tender

Chemical name Line item

Brinzolamide

Eye Drops 1%

Cetirizine hydrochloride

Tab 10 mg

Hydrocortisone

Crm 1% (pack size greater than 100 g)

Hydrocortisone

Crm 1% (pack size greater than 15 g and less than 100 g)

Sodium chloride

Inj 0.9%, 5 ml

Sodium chloride

Inj 0.9%, 10 ml

Sodium chloride

Inj 0.9%, 20 ml

Sodium chloride

Soln 0.9% for irrigation, 30 ml

Travoprost

Eye drops 0.004%

Water for Injection

Purified for inj 5 ml

Water for Injection

Purified for inj 10 ml

Water for Injection

Purified for inj 20 ml

Wool fat

Crm

Zinc and castor oil

Oint BP (pack size greater than 30 g)

2014/15 Invitation to Tender

Chemical name Line item

Ambrisentan

Tab 5 mg

Ambrisentan

Tab 10 mg

Carboplatin

Inj 10 mg per ml, 100 ml

Doxorubicin hydrochloride

Inj 10 mg

Enoxaparin sodium

Inj 20 mg per 0.2 ml

Enoxaparin sodium

Inj 40 mg per 0.4 ml

Enoxaparin sodium

Inj 60 mg per 0.6 ml

Enoxaparin sodium

Inj 80 mg per 0.8 ml

Enoxaparin sodium

Inj 100 mg per ml, 1 ml

Enoxaparin sodium

Inj 120 mg per 0.8 ml

Enoxaparin sodium

Inj 150 mg per ml, 1 ml

Fluorouracil sodium

Inj 50 mg per ml, 10 ml

Idarubicin Hydrochloride

Cap 5 mg

Idarubicin Hydrochloride

Cap 10 mg

Lidocaine [Lignocaine] Hydrochloride

Inj 1%, 2 ml

Lidocaine [Lignocaine] Hydrochloride

Inj 2%, 2 ml

Mitozantrone

Inj 2 mg per ml, 5 ml

Mitozantrone

Inj 2 mg per ml, 12.5 ml

Pancreatic enzyme

Cap EC 24,000-25,000 BP u lipase, 22,000-23,000 BP u amylase and 1,000-1,500 BP u protease

Promethazine Hydrochloride

Inj 25 mg per ml, 2 ml

Propranolol

Tab 10 mg

Propranolol

Tab 40 mg

Single chamber empty IV infusion bags

DEHP-free IV infusion bag, 250 ml

Single chamber empty IV infusion bags

DEHP-free IV infusion bag, 500 ml

Single chamber empty IV infusion bags

DEHP-free IV infusion bag, 1,000 ml

Single chamber empty IV infusion bags

Latex-free IV infusion bag, 250 ml

Single chamber empty IV infusion bags

Latex-free IV infusion bag, 500 ml

Single chamber empty IV infusion bags

Latex-free IV infusion bag, 1,000 ml

Single chamber empty IV infusion bags

PVC-free IV infusion bag, 250ml

Single chamber empty IV infusion bags

PVC-free IV infusion bag, 500 ml

Single chamber empty IV infusion bags

PVC-free IV infusion bag, 1,000 ml

Single chamber empty IV infusion bags

PVC-free, DEHP-free and latex-free IV infusion bag, 250 ml

Single chamber empty IV infusion bags

PVC-free, DEHP-free and latex-free IV infusion bag, 500 ml

Single chamber empty IV infusion bags

PVC-free, DEHP-free and latex-free IV infusion bag, 1,000 ml

Testosterone

Transdermal patch 2.5 mg

Testosterone

Transdermal patch 5 mg

Tobramycin

Inj 100 mg per ml, 5 ml vial

Tobramycin

Powder BP

Trimethoprim with sulphamethoxazole [Co-trimoxazole]

Inj 16 mg with sulphamethoxazole 80 mg per ml, 5 ml ampoule

For products included in the 2013/14 and 2014/15 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.